ZymoGenetics, Inc. (ZGEN) Q1 2010 Earnings Call May 4, 2010 4:30 pm ET Executives Susan. Specht - Director, Corporate Communications Doug Williams - CEO Jim Johnson - CFO Stephen Zaruby - President Lennie Ramos - CMO Analysts John - Leerink Swann Brian Abrahams - Oppenheimer and Company David Miller - Biotech Stock Research Ted Tenthoff - Piper Jaffray Paul Latta - McAdams Wright Ragen Jeremiah Shepard - Wedbush Inc PresentationOperator
Welcome to the ZymoGenetics First Quarter 2010 Financial Results. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. (Operator Instructions). As a reminder this conference is being recorded. It is now my pleasure to introduce to your host Susan. Specht, Senior Director of Corporate Communications for ZymoGenetics. Thank you Ms. Specht, you may begin. Susan Specht Good afternoon everyone, welcome to our first quarter 2010 conference call. Before we begin I would like to remind you that we will be making forward-looking statements as part of our prepared remarks and in answering your questions. These statements are subject to many risks and uncertainties that could cause actual outcomes to be much different than we predict. Please look at our SEC filings, including the Form 10-K for more information. Now, I will turn the call over to our CEO Doug Williams. Doug Williams Thank you Susan, and welcome to all of you on today’s call. I am joined today by Stephen Zaruby our President and Lennie Ramos our CMO as well as Jim Johnson, our CFO, who will review Q1 financial performance you. Let me start with the corporate review and then Jim will summarize the financials and we will be available to answer your questions after that.